In melanoma patients, CD141+ DCs, as the most migratory DC subpopulation, deliver tumor antigens to the TDLN via a CCR7-dependent pathway, and are a key cell type for initiating CD8+ T cell responses (49). This evidence concerns the gene CD8A and neoplasm.